Examining EGFR-mediated PI3K/Akt pathway in combination therapy of cetuximab and dynamin inhibition

被引：0
|
作者：
Chew, Hui Yi [1 ]
Panizza, Benedict [2 ]
Cooper, Caroline [3 ]
Dolcetti, Riccardo [1 ]
Coward, Jim [4 ]
McCluskey, Adam [5 ]
Robinson, Phillip J. [6 ]
Wells, James W. [1 ]
Simpson, Fiona [1 ]
机构：
[1] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Princess Alexandra Hosp, Otolaryngol Head & Neck Surg Dept, Brisbane, Qld, Australia
[3] Princess Alexandra Hosp, Pathol Queensland, Brisbane, Qld, Australia
[4] Icon Canc Ctr, Brisbane, Qld, Australia
[5] Univ Newcastle, Ctr Chem Biol & Clin Pharmacol, Callaghan, NSW, Australia
[6] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW, Australia
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B12
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [1] Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway
    Shao, Jingwei
    Zheng, Guirong
    Chen, Hongning
    Liu, Jian
    Xu, Aixiao
    Chen, Fan
    Li, Tao
    Lu, Yusheng
    Xu, Jianguo
    Zheng, Ning
    Jia, Lee
    [J]. ONCOTARGET, 2017, 8 (45) : 78351 - 78364
  • [2] Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
    Ganesan, Kumar
    Xu, Cong
    Wu, Jianming
    Du, Bing
    Liu, Qingqing
    Sui, Yue
    Song, Cailu
    Zhang, Jinhui
    Tang, Hailin
    Chen, Jianping
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (09) : 1849 - 1866
  • [3] Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
    Kumar Ganesan
    Cong Xu
    Jianming Wu
    Bing Du
    Qingqing Liu
    Yue Sui
    Cailu Song
    Jinhui Zhang
    Hailin Tang
    Jianping Chen
    [J]. ScienceChina(LifeSciences)., 2024, 67 (09) - 1866
  • [4] Investigation of EGFR/pi3k/Akt signaling pathway in seminomas
    Guerra, F.
    Quintana, S.
    Giustina, S.
    Mendeluk, G.
    Jufe, L.
    Avagnina, M. A.
    Diaz, L. B.
    Palaoro, L. A.
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2021, 96 (02) : 125 - 137
  • [5] PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
    Babichev, Yael
    Kabaroff, Leah
    Datti, Alessandro
    Uehling, David
    Isaac, Methvin
    Al-awar, Rima
    Prakesch, Michael
    Sun, Ren X.
    Boutros, Paul C.
    Venier, Rosemarie
    Dickson, Brendan C.
    Gladdy, Rebecca A.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [6] PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
    Yael Babichev
    Leah Kabaroff
    Alessandro Datti
    David Uehling
    Methvin Isaac
    Rima Al-awar
    Michael Prakesch
    Ren X. Sun
    Paul C. Boutros
    Rosemarie Venier
    Brendan C. Dickson
    Rebecca A. Gladdy
    [J]. Journal of Translational Medicine, 14
  • [7] Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
    LoRusso, Patricia Mucci
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3803 - +
  • [8] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis
    Barra, Fabio
    Desideri, Lorenzo Ferro
    Ferrero, Simone
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) : 3626 - 3627
  • [9] Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
    Morgan, Todd M.
    Koreckij, Theodore D.
    Corey, Eva
    [J]. CURRENT CANCER DRUG TARGETS, 2009, 9 (02) : 237 - 249
  • [10] Naphthoquinone Derivatives from the Endophytic Fungus Fusarium solani Induce Pancreatic Cancer Cells Apoptosis via Targeting EGFR-Mediated PI3K/Akt Pathway
    Gao, Lin-Lin
    Fang, Xu-Tong
    Zhao, Shu-Hui
    Hui, Chen-Xiao
    Huang, Wei-Wei
    Gao, Yu-Qi
    Gao, Jin-Ming
    [J]. Journal of Agricultural and Food Chemistry, 2024, 72 (47) : 26209 - 26223
12345